Immatics stock holds near USD 9.60 after market cap update
Published on 09/04/2026 at 16:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Immatics N.V. (NL0015255052) stock traded at USD 9.60 on September 3, 2026, with a market capitalization of USD 1.41 billion and a session range between USD 9.26 and USD 9.69, according to Robinhood. The shares finished 3.7 percent above the low and 0.9 percent below the high.
Price sits near the range
The quoted range puts Immatics close to the top of its latest trading band, and the 1.41 billion USD market cap shows the current equity value attached to that move. Robinhood also lists a negative P/E ratio of -5.14, a reminder that the market is still valuing the company on expectations rather than near-term earnings power.
Balance sheet and pipeline
Immatics reported cash and cash equivalents of USD 394.2 million at June 30, 2026, after closing the second quarter with a net loss of USD 43.6 million. Research and development spending reached USD 52.4 million in the same quarter, while collaboration revenue was USD 5.3 million and total revenue was USD 8.0 million.
That quarter also showed how costly late-stage development remains: operating expenses were USD 66.1 million, more than eight times the collaboration revenue booked in the period. For investors, the gap between USD 8.0 million in revenue and USD 52.4 million in R&D is the key operating contrast.
Immatics pipeline and cash position
The most relevant question now is how long the USD 394.2 million cash position can support development work while the clinical pipeline advances.
Lead program stays central
The company describes its business around cancer immunotherapies, and that makes the clinical pipeline the main driver behind valuation swings rather than current earnings. In the second quarter of 2026, collaboration revenue was USD 5.3 million, but the company still spent USD 52.4 million on research and development.
Trading view
Immatics stock ended September 3, 2026 at USD 9.60, and the market cap of USD 1.41 billion gives the move a clear size. The stock is listed on Nasdaq under IMTX in the biotechnology sector.
Immatics N.V. at a glance
- Company: Immatics N.V.
- ISIN: NL0015255052
- Ticker: IMTX
- Trading venue: Nasdaq
- Price (as of September 3, 2026): USD 9.60
- Market capitalization: USD 1.41 billion (as of September 4, 2026)
- Sector / Industry: Health Care / Biotechnology
